This digital event explored the introduction of pressurised metered-dose inhalers (pMDIs) using next-generation propellants with near-zero global warming potential. These innovations preserve proven efficacy and patient familiarity while significantly reducing environmental impact. By bringing together leading respiratory experts, the session highlighted environmental, clinical, and practical considerations for pharmacists. Participants gained insights into the importance of maintaining people-centred care during this transition while also supporting health systems’ sustainability goals.
Advancing sustainable respiratory care: next-generation propellants in inhalers
